About: Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic
Creator	Choudhury, M Muthukumar, D Nageshwaran, S
Source	Elsevier; Medline; PMC
abstract	covid:659a760f5a7e3038a2d2406049a9636e56fd9810#abstract
has issue date	2020-07-08(xsd:dateTime)
bibo:doi	10.1016/j.clon.2020.07.003
bibo:pmid	32684506
has license	els-covid
sha1sum (hex)	659a760f5a7e3038a2d2406049a9636e56fd9810
schema:url	https://doi.org/10.1016/j.clon.2020.07.003
resource representing a document's title	Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic
has PubMed Central identifier	PMC7342028
has PubMed identifier	32684506
schema:publication	Clin Oncol (R Coll Radiol)
resource representing a document's body	covid:659a760f5a7e3038a2d2406049a9636e56fd9810#body_text
is schema:about of	named entity 'pembrolizumab' named entity 'COVID-19 pandemic' named entity 'pemetrexed' named entity 'non-small cell lung cancer' named entity 'NSCLC' named entity 'COVID-19' named entity 'TPS' named entity 'COVID-19' named entity 'European Medicines Agency' named entity 'pembrolizumab' named entity 'COVID-19 Pandemic' named entity 'NHS England' named entity 'Non-small Cell Lung Cancer' named entity 'TPS' named entity 'TPS' named entity 'metastatic' named entity 'monotherapy' named entity 'immunotherapy' named entity 'myelosuppression' named entity 'adverse events' named entity 'progression-free survival' named entity 'immunosuppression' named entity 'progression-free survival' named entity 'pemetrexed' named entity 'infection' named entity 'pembrolizumab' named entity '7.2' named entity 'NSCLC' named entity 'monotherapy' named entity 'adverse events' named entity 'adverse events' named entity 'NHS England' named entity 'metastatic' named entity 'pemetrexed' named entity 'TPS' named entity 'pemetrexed' named entity 'TPS' named entity '5.4' named entity 'immunotherapy' named entity 'TPS' named entity 'adverse events' named entity 'TPS' named entity 'Immunotherapy' named entity '3, 4' named entity 'TPS' named entity 'TPS' named entity 'tumour' named entity 'monotherapy' named entity 'NSCLC' named entity 'TPS' named entity 'TPS' named entity 'TPS' named entity 'pembrolizumab' named entity 'chemotherapy' named entity 'monotherapy' named entity '20%' named entity 'COVID-19 PANDEMIC' named entity 'METASTATIC NON-SMALL CELL LUNG CANCER' named entity 'EVIDENCE' named entity 'NHS' named entity 'Metastatic' named entity 'Lung Cancer' named entity 'COVID-19' named entity 'ENGLAND' named entity 'JOURNAL ' named entity 'PRE' named entity 'INTERIM' named entity 'LACKING' named entity 'GUIDANCE' named entity 'Journal' named entity 'Pandemic' named entity 'Cell' named entity 'NHS England' named entity 'Metastatic' named entity 'Evidence' named entity 'MANAGING' named entity 'PROOF'
is part of of	Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic covid:659a760f5a7e3038a2d2406049a9636e56fd9810#abstract

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software